GSK’s Ingram joins Allergan’s board
Executive Summary
GlaxoSmithKline Vice Chairman-Pharmaceuticals Bob Ingram is joining Allergan's board of directors. He sits on the board of several corporations, including Edwards Lifesciences and Lowe's, as well as serving as chairman of the board of OSI Pharmaceuticals (1"The Pink Sheet" Jan. 13, 2003, In Brief). Ingram's relationship with Allergan is somewhat noteworthy as both Allergan and GSK are members of the Pharmaceutical Research & Manufacturers of America...
You may also be interested in...
OSI hires GSK’s Ingram
GlaxoSmithKline Vice Chairman-Pharmaceuticals Robert Ingram joins OSI Pharmaceuticals as chairman of board of directors in a non-executive capacity, effective Jan. 1. "Ingram will assume chairmanship of the Board's executive, nominating and compensation committees," OSI said. OSI CEO Colin Goddard relinquishes chairmanship of board. Ingram retired as GSK chief operating officer and pharmaceutical operations president in December (1"The Pink Sheet" Oct. 21, 2002, p. 27)...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.